ZhuZhou QianJin Pharmaceutical Co.,Ltd

シンボルマーク: 600479.SS

SHH

10.91

CNY

今日の市場価格

17.9517
PER（株価収益率
0.4616
PEGレシオ
4.56B
MRK キャップ
0.03%
DIV利回り

ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479-SS) 財務諸表

Q: ZhuZhou QianJin Pharmaceutical Co.,Ltd600479.SS 総資産とは何ですか？

ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) 総資産は .

Q: 企業のフリーキャッシュフローとは？

フリーキャッシュフローは .

Download

年次四半期

リニア対数

チャート上ではのダイナミクスにおけるデフォルトの数値を見ることができる。ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS). 会社の収益は NaN M の平均を示し、これは NaN % の成長率です。全期間の平均売上総利益は NaN M であり、NaN % である。平均売上総利益率は NaN % である。昨年度の純利益成長率はNaN % で, NaN % % に等しい。に等しい.,

年次四半期

10Y 20Y 30Y 40Y

貸借対照表

ZhuZhou QianJin Pharmaceutical Co.,Ltdの財政の軌跡に飛び込むと、平均的な資産の伸びが観察される。この率は、興味深いことに、であり、会社の最高と最低の両方を反映している。前期比で比較すると、この数字はに調整される。過去1年間を振り返ってみると、総資産の変動は NaN となる. 総株主資本によって示される株主価値は、報告通貨でのNaN で評価される。この面の前年比変化はNaN% である.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
balance-sheet.row.cash-and-short-term-investments	1997.9	1731.7	1369.7	1407.6	1378	1100.2	690.3	736.2	544.3	297	205.3	243.2	217.7	334.9	416.9	507.4	527.4	435.8	410.4	383.6	71.3	72.9	93.4
balance-sheet.row.short-term-investments	-45.7	491.7	736.8	652.3	-39.6	109.1	182.2	7.8	31.1	69.6	22.1	92.5	98.5	60.3	232	0.2	130	35	6	6.1	0	0	0.2
balance-sheet.row.net-receivables	967	983.9	921.6	1164.8	1078.8	972.4	1043	951.2	843.5	876.3	743	610.6	558.1	307.8	260.4	196.8	105.9	113.7	143.4	160.4	113.9	82.8	97.7
balance-sheet.row.inventory	534.1	599	547.8	496.8	469.5	440.9	376.3	358.5	272.3	243.2	222.5	195.3	117	126.5	98.8	96.5	82.9	87.3	75.1	84.1	84.9	71	77.5
balance-sheet.row.other-current-assets	15.4	198.9	78.1	120.2	29	82.9	319.7	87.2	267.7	27	5.6	6.7	-29.7	-12.6	-9.8	-12.1	-4.2	-7.1	-8.7	-13.2	-11.6	-13.5	-19.4
balance-sheet.row.total-current-assets	3514.5	3513.5	2917.3	3189.3	2955.3	2596.3	2429.2	2133	1927.8	1443.6	1176.4	1055.8	863.1	756.5	766.3	788.6	711.9	629.7	620.1	614.8	258.5	213.1	249.1
balance-sheet.row.property-plant-equipment-net	589.9	622.8	630.2	491	478.7	499.8	529.2	565.4	491.4	415.2	396.8	334.6	309.8	285.4	286.7	193.2	153.4	154.6	160	163	150.2	134.7	77.3
balance-sheet.row.goodwill	14.1	14.1	14.1	14.1	14.1	14.1	14.1	14.1	14.1	14.1	14.1	8.7	8.7	8.7	8.7	8.7	8.7	0	0	0	0	0	0
balance-sheet.row.intangible-assets	238.3	221.8	219.6	216.4	255.2	285.8	241.2	259.8	260.4	247.3	252.8	199.5	45.3	46.5	47.7	47.1	20.2	20.2	4.4	4.6	4.6	4.5	4.6
balance-sheet.row.goodwill-and-intangible-assets	252.3	235.9	233.7	230.5	269.3	299.9	255.3	273.9	274.5	261.4	266.9	208.2	54	55.2	56.5	55.8	28.9	20.2	4.4	4.6	4.6	4.5	4.6
balance-sheet.row.long-term-investments	293.3	-304.1	-546.1	-462	103	-63.7	-136.8	37.6	4.3	-33.2	14.2	-57.2	-57	-40.5	-86.9	13.4	54	-16.4	3.9	0.5	0	0	0.4
balance-sheet.row.tax-assets	22.7	6.6	4.1	4.2	4.2	4.6	6.9	4	3.4	2.5	2.7	1.3	2.1	0.9	0.5	0.5	1.4	0	0	0	0	0	1.3
balance-sheet.row.other-non-current-assets	4.2	547.3	821	775.7	1.7	135.7	203	18.2	41.9	139.5	31.2	102.4	109.7	71	242.8	7.9	135.6	40.7	9.8	9.7	7.9	7.6	0
balance-sheet.row.total-non-current-assets	1162.4	1108.5	1143	1039.4	856.9	876.2	857.6	899.1	815.4	785.4	711.9	589.4	418.6	371.9	499.5	270.8	373.3	199	178.1	177.7	162.8	146.8	83.6
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	4676.9	4622	4060.2	4228.7	3812.2	3472.5	3286.9	3032.1	2743.2	2228.9	1888.3	1645.2	1281.7	1128.5	1265.8	1059.4	1085.3	828.7	798.2	792.5	421.3	359.9	332.8
balance-sheet.row.account-payables	647.5	780.9	511.7	623	529.1	485.8	469.5	446	317	369.4	168.9	86.1	80.2	80.7	109	91.7	82	81	56.1	69.5	74.6	49.1	77.3
balance-sheet.row.short-term-debt	78.2	79.5	88.6	135.9	1.9	1	1	0.5	3.1	61	87	115.9	0	0	131	0	0	0	0	12	33.1	32.8	1.5
balance-sheet.row.tax-payables	70.6	72.5	35.6	45.2	41	61.3	67.5	32.9	23.1	41.6	28.4	28.4	34.3	10	15.2	26.6	23.7	23.2	11.3	11.6	18.9	17.1	12.9
balance-sheet.row.long-term-debt-total	38.5	44.8	60.3	19.5	20.5	26.7	37.3	47.3	54	32	5.2	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	8.7
Deferred Revenue Non Current	38	44.4	51.3	51.8	42.8	44.4	51.5	50.2	52.9	41.6	44.5	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	69.1	705.6	75.5	84.9	192.3	407.8	130.1	165.4	149.6	125	97.9	76.8	181.3	81.5	19.5	89.4	83.6	85.5	144.7	1.9	5.5	1.6	0.7
balance-sheet.row.total-non-current-liabilities	108.3	108.5	131.9	89	81.5	86.6	111.3	111.2	117.6	84.3	55.3	30	26.6	26.5	2.6	2.6	23.7	2.6	2.6	3	3.4	3.4	11.5
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	31.5	32.8	44.8	42.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	1650.1	1805.7	1360.3	1466.7	1182.6	1042.5	1045.7	948.2	779.2	843.2	683.9	581.2	288.1	188.6	314.5	183.7	189.3	169.1	203.4	148.4	188.2	174.3	182.8
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	428.9	429.8	418.5	418.5	418.5	418.5	348.8	348.8	348.8	304.8	304.8	304.8	304.8	304.8	217.7	181.4	151.2	126	84	56	38	38	38
balance-sheet.row.retained-earnings	1142.5	970.8	930.7	1047.2	959.4	826.1	694.2	568.4	481.4	456.1	414.1	377.7	328.3	328.2	356.9	295.8	260.5	115.5	60.7	122.1	114.1	71.9	57.3
balance-sheet.row.accumulated-other-comprehensive-income-loss	280.8	275.3	298.1	298.1	297.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	537.5	540.3	503	503	503	784.2	834.4	828.5	816.7	360.6	289.3	283.5	275.2	268.6	349.4	374.2	463	399	433.8	452.5	64.8	56	40.1
balance-sheet.row.total-stockholders-equity	2389.7	2216.2	2150.4	2266.8	2178.1	2028.8	1877.4	1745.7	1646.8	1121.5	1008.2	966	908.3	901.6	924	851.4	874.6	640.6	578.5	630.6	216.9	165.8	135.4
balance-sheet.row.total-liabilities-and-stockholders-equity	4676.9	4622	4060.2	4228.7	3812.2	3472.5	3286.9	3032.1	2743.2	2228.9	1888.3	1645.2	1281.7	1128.5	1265.8	1059.4	1085.3	828.7	798.2	792.5	421.3	359.9	332.8
balance-sheet.row.minority-interest	637.1	600.1	549.5	495.2	451.5	401.1	363.8	338.2	317.2	264.3	196.2	98	85.3	38.2	27.3	24.3	21.3	19	16.4	13.5	16.1	19.7	14.5
balance-sheet.row.total-equity	3026.8	2816.3	2699.9	2762	2629.6	2430	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	247.6	187.6	190.8	190.3	63.4	45.3	45.3	45.3	35.3	36.3	36.3	35.3	41.6	19.8	145.1	13.6	184	18.6	10	6.5	6.5	5.5	0.5
balance-sheet.row.total-debt	116.7	124.2	148.9	155.4	22.4	27.7	38.3	47.8	57.1	93	87	115.9	0.7	0.7	131	0.7	0.7	0.7	0.7	12	33.1	32.8	1.5
balance-sheet.row.net-debt	-1881.2	-1115.7	-484	-600	-1355.5	-963.4	-469.8	-680.6	-456.1	-134.4	-96.2	-34.8	-118.5	-274	-53.9	-506.6	-396.7	-400.1	-403.7	-365.5	-38.2	-40.1	-91.7

キャッシュフロー計算書

ZhuZhou QianJin Pharmaceutical Co.,Ltd の財務状況は、直近の期間においてフリー・キャッシュ・フローに顕著な変化が見られ、NaN の推移を示している。同社は最近、NaN を発行して株式資本を拡大し、前年度と比較してNaN の差を示した. 当社の投資活動は、報告通貨で NaN に相当する正味現金使用量をもたらしました。これは、NaN の前年からのシフトです. 同時期に、同社は NaN, NaN、および NaN を記録しており、同社の投資および返済戦略を理解する上で重要です. 財務活動によるキャッシュ・フローはNaN となり、前年同期との差はNaN となった。また、NaN を株主への配当に充当した。同時に、NaN と呼ばれるその他の財務操作も行っており、これらもこの期間のキャッシュフローに大きな影響を与えた. これらの要素を総合すると、会社の財務状況とキャッシュフロー管理に対する戦略的アプローチの包括的な絵が描かれる。

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
cash-flows.row.net-income	395	388.3	374.7	360.2	352.1	302.6	246.7	173.4	88.3	117.7	128.8	130.9	94.8	97.6	136.9	134.5	176.6	75	61.7	46.6	48.4	38.9
cash-flows.row.depreciation-and-amortization	103.7	95.6	85.9	60.9	61.1	61.8	62.7	50.2	50.4	48.5	48.3	40	38.3	36	25.2	21.8	20.9	24.3	23.3	22	18.3	13.1
cash-flows.row.deferred-income-tax	-2.8	-3.6	2.7	1.4	-0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	2.8	3.6	-2.7	-1.4	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-81.7	246.9	65.8	129.5	-233	29.3	-11.8	-81.8	-73.8	15.1	-49.5	40.4	-122.7	-81.4	-68.9	-88.6	2.4	47.2	-1.1	-46.4	-19.4	-45.6
cash-flows.row.account-receivables	-8.7	-163.7	275.9	27.2	-362.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	62.3	-51.2	-52.4	-27.3	-29.1	-64.7	-17.9	-85.5	-29.9	-22.4	-19.8	-78.4	9.6	-27.7	-2	-13.2	3.7	1.7	8.3	1	-13.8	3.1
cash-flows.row.account-payables	-132.5	465.4	-160.4	128.2	159.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	-2.8	-3.6	2.7	1.4	-0.9	94	6.1	3.8	-44	37.4	-29.6	118.8	-132.3	-53.7	-66.8	-75.4	-1.3	45.5	-9.4	-47.4	-5.6	-48.7
cash-flows.row.other-non-cash-items	26.1	2.7	-40.9	-8.2	-24.7	-10.2	-14.1	-0.9	2.6	2.1	10.1	-13.6	12.2	-13	-19.7	-30.4	-120.6	-26.3	-7.5	-3.8	3.6	-0.3
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-44	-34.4	-71.9	-97.2	-40.6	-46.4	-57.3	-81.5	-84.5	-66	-84.3	-256.3	-63.9	-58.4	-123.3	-95.3	-22.5	-21.4	-16.7	-56.5	-34	-59.2
cash-flows.row.acquisitions-net	0	0.2	30.8	103.6	73	0	13	0.7	85	1.2	-21.4	0.6	1.3	5.8	0.8	0.3	0.8	2.1	0.6	1	0.1	0.2
cash-flows.row.purchases-of-investments	-402	-2102	-1570	-2641	-285	-904	-1403.9	-1001.7	-769.6	-405	-135.1	-235.4	-891.1	-565.5	-1545.8	-1482	-576.3	-855.2	-1103.4	-225.3	-1	-5
cash-flows.row.sales-maturities-of-investments	1031.2	2258.4	1567.7	1770.3	469.5	1222.9	1006.1	1197.1	605.1	357.6	207.4	266.3	820.6	889.9	1194	1728.4	549.6	845.8	1107.5	219.4	0.5	0.3
cash-flows.row.other-investing-activites	0.1	0	0	-97.2	-40.6	2.5	24.3	5.9	-84.5	0.4	0.1	0	-3.9	1.6	2.8	2.8	3.1	2.4	1.8	3.7	2	1.6
cash-flows.row.net-cash-used-for-investing-activites	585.3	122.1	-43.3	-961.5	176.3	275	-417.8	120.6	-248.5	-111.8	-33.3	-224.7	-137	273.3	-471.5	154.1	-45.3	-26.3	-10.3	-57.8	-32.5	-62.2
cash-flows.row.debt-repayment	-50.7	-15	-127.6	-19.1	-6.2	-10.6	-9.5	-9.3	-105	-147	-180.9	-7.5	-20	-605	-4937	0	-550	-700	-12	-333.7	-39.7	-15.3
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-147.9	-248.6	-429.5	-209.3	-167.1	-105	-71.4	-54.4	-66.7	-60.7	-79.9	-61.3	-76.2	-108.9	-59.5	-79.6	-36.4	-96	-28.2	-32.1	-22	-7.7
cash-flows.row.other-financing-activites	-13.1	-0.5	36.5	124.2	-7.4	-9.1	-12.7	-1.2	620	154.9	180.8	125	55.2	497.8	5065.6	-1.9	548.9	698.6	0.9	711.3	41.7	58.8
cash-flows.row.net-cash-used-provided-by-financing-activities	-202	-264.2	-520.6	-104.2	-180.7	-124.7	-93.6	-65	448.4	-52.8	-80	56.2	-41.1	-216.1	69.1	-81.5	-37.4	-97.3	-39.3	345.5	-20	35.8
cash-flows.row.effect-of-forex-changes-on-cash	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	826.4	591.4	-78.3	-523.4	151.1	533.7	-227.9	196.4	267.4	18.8	24.3	29.3	-155.4	96.3	-328.9	109.9	-3.4	-3.6	26.9	306.2	-1.5	-20.3
cash-flows.row.cash-at-end-of-period	1928.3	1101.9	510.5	588.8	1112.3	961.2	427.4	655.4	458.9	191.5	172.8	148.5	119.2	274.6	178.4	507.2	397.4	400.8	404.3	377.5	71.3	72.9
cash-flows.row.cash-at-beginning-of-period	1101.9	510.5	588.8	1112.3	961.2	427.4	655.4	458.9	191.5	172.8	148.5	119.2	274.6	178.4	507.2	397.4	400.8	404.3	377.5	71.3	72.9	93.2
cash-flows.row.operating-cash-flow	443.1	733.5	485.6	542.4	155.5	383.5	283.5	140.9	67.5	183.3	137.6	197.8	22.6	39.1	73.5	37.2	79.3	120.1	76.5	18.5	51	6.1
cash-flows.row.capital-expenditure	-44	-34.4	-71.9	-97.2	-40.6	-46.4	-57.3	-81.5	-84.5	-66	-84.3	-256.3	-63.9	-58.4	-123.3	-95.3	-22.5	-21.4	-16.7	-56.5	-34	-59.2
cash-flows.row.free-cash-flow	399.1	699	413.7	445.1	114.9	337.1	226.2	59.4	-17	117.4	53.4	-58.4	-41.3	-19.3	-49.8	-58.1	56.7	98.7	59.8	-38	16.9	-53.2

損益計算書の行

ZhuZhou QianJin Pharmaceutical Co.,Ltd の売上は前期比 NaN% の変化。600479.SS の売上総利益は NaN と報告されている。同社の営業費用は NaN で、前期比NaN% の変化を示している. 減価償却費は NaN であり、前期からの増減率は NaN% である。営業費用は NaN と報告されており、前年比NaN% の変化を示している。販売・マーケティング費用は NaN で、前年度比 NaN% の変化である。直近の数字に基づくEBITDAは NaN で、前年比NaN% の伸びを示す。営業利益は NaN で、前年度比NaN% の変化を示している。当期純利益の増減率は NaN%。前年度の当期純利益は NaN であった。

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
income-statement-row.row.total-revenue	3798.5	4026.3	3663.8	3627	3525.2	3328.6	3182.7	2864.9	2446.7	2194.2	1972.9	1583.4	1256.5	979.4	904.3	801.4	679.8	602.7	665.8	604.9	686.8	582	560.2
income-statement-row.row.cost-of-revenue	2046.7	2289.9	2032.2	2030.8	1918.7	1776.3	1743.2	1573.3	1311.5	1141.1	1006.8	786.3	603.5	427.9	360.8	345.8	322.3	309.4	423.8	409.4	476.1	405.9	417.3
income-statement-row.row.gross-profit	1751.8	1736.4	1631.6	1596.2	1606.5	1552.3	1439.5	1291.6	1135.2	1053.1	966	797.1	653	551.6	543.4	455.6	357.5	293.3	242	195.5	210.7	176.1	142.9
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-3337.9	218.6	189.1	156.1	147.8	14.9	-9.7	13.6	15	10.5	3.7	0.7	1.6	8.1	1.7	-1.1	0.1	1.2	1.3	1.8	-0.8	-0.9	-2
income-statement-row.row.operating-expenses	3337.9	1311.7	1261.1	1224.8	1247.8	1249.1	1170.9	1111.7	1042.9	924.3	810.4	663.7	536.5	474	404.5	345.3	282.9	237.7	178	146.3	142.3	118.1	92.9
income-statement-row.row.cost-and-expenses	3337.9	3601.5	3293.4	3255.6	3166.5	3025.4	2914.1	2685	2354.4	2065.4	1817.2	1450	1140.1	901.8	765.3	691	605.2	547.1	601.8	555.7	618.4	524	510.1
income-statement-row.row.interest-income	51.4	9.8	11.9	30.4	38.6	20.9	11.7	10.9	4.6	1.2	0.2	1.7	4.1	1.6	0	0	0	2.4	1.8	3.7	1.9	1.6	1.7
income-statement-row.row.interest-expense	1.7	2.2	2.1	2.2	0.4	0.7	2.6	2.8	6.5	6.1	4.1	2.1	0.2	0.1	-1	-1.9	0.7	1.1	0.1	1.2	2.3	1.1	0.3
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-1.5	1.6	-2.8	0.4	-1.1	49.1	18	26.5	17.3	11.6	-2.8	17.9	-6.8	31.9	17.1	31.4	123.3	27.9	9.1	6.5	1.2	1.3	-0.5
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-3337.9	218.6	189.1	156.1	147.8	14.9	-9.7	13.6	15	10.5	3.7	0.7	1.6	8.1	1.7	-1.1	0.1	1.2	1.3	1.8	-0.8	-0.9	-2
income-statement-row.row.total-operating-expenses	-1.5	1.6	-2.8	0.4	-1.1	49.1	18	26.5	17.3	11.6	-2.8	17.9	-6.8	31.9	17.1	31.4	123.3	27.9	9.1	6.5	1.2	1.3	-0.5
income-statement-row.row.interest-expense	1.7	2.2	2.1	2.2	0.4	0.7	2.6	2.8	6.5	6.1	4.1	2.1	0.2	0.1	-1	-1.9	0.7	1.1	0.1	1.2	2.3	1.1	0.3
income-statement-row.row.depreciation-and-amortization	103.7	104.2	47.3	60.3	40.8	61.8	62.7	50.2	50.4	48.5	48.3	40	38.3	36	25.2	21.8	20.9	24.3	23.3	22	18.3	13.1	-1.9
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	460.6	444.2	436.2	424.2	430.8	337.4	296.3	194	94.8	130.4	150	150.9	108.1	101.5	155.2	143.1	198.9	83.9	74.3	55.3	71.5	60.2	51.9
income-statement-row.row.income-before-tax	459.1	445.8	433.4	424.6	429.7	352.3	286.6	206.4	109.6	140.4	152.8	151.3	109.7	109.5	156.1	141.8	197.9	84.3	74.3	56.4	70.1	59.3	49.7
income-statement-row.row.income-tax-expense	65.4	57.6	58.7	64.4	77.6	49.7	40	33	21.3	22.7	24.1	20.4	14.9	12	19.1	7.3	21.3	9.4	12.6	9.8	21.7	20.3	14.4
income-statement-row.row.net-income	320.4	302.5	302.1	297.1	294.3	255.4	207.8	149.4	93	105.1	123.8	120.2	82.8	86.4	130.9	129.9	173.6	71.8	59.9	45.4	50.1	39.8	34.5